You raised the round to run experiments. Not to run software.
Optivant OS maps what you're actually paying for, retires what nobody uses, and automates the commercial work your team is doing by hand — built by someone who worked alongside life sciences companies every day.
Five things that quietly cost you a quarter.
Three hundred badge scans from BIO
The show ends, the list goes into a spreadsheet, and three weeks later somebody starts emailing. The warm ones went cold on day four.
The BD pipeline lives in one inbox
Partnering conversations, CDA status, who owes whom a follow-up — held in one person's head and one person's email. When they're travelling, it stops.
Software bought on investor money, owned by nobody
Benchling, Slack, HubSpot, Box, DocuSign, Notion, the ELN, and a dozen orphaned seats from people who left. No register, no owner, no review.
Board reporting rebuilt by hand every quarter
Someone spends three days assembling the same slides from the same six systems, four times a year.
Grant and SBIR milestones tracked on calendar reminders
Reporting deadlines that matter enormously, managed with the same tool you use to book lunch.
The application register is where we start.
Most 10–100 person life sciences companies we assess are carrying between fifteen and forty active software subscriptions. Nobody has a current list. The assessment produces one in 48 hours — every tool, what it costs, who actually logs in — and that document usually pays for itself before we automate anything.
- Duplicate capability across tools
- Seats billing for people who left
- Annual renewals nobody diarised
- Point solutions that a platform you already own replaces
- Spend that never had an owner
The pharma BD team reading your pipeline page will never fill out a form.
Most of the traffic that matters to a small biotech is anonymous — corporate development teams, VC associates doing diligence, CRO and CDMO business development. Account Intelligence matches business visitors to the company level and surfaces them in your CRM with the pages they viewed and when. Company-level only, no individual identification, no automated outreach. It is a signal for a human to act on.
A top-twenty pharma reading your pipeline page three times in a week is the highest-value intelligence a company your size can get. Today most of you never see it.
How Account Intelligence worksFour systems, translated.
Conference follow-up that runs itself
Badge scan to CRM to first contact, inside sixty seconds, for the whole show floor. Segmented by what they stopped to talk about.
Partnering meetings that hold
Reminders and confirmations for BD calls and site visits, updating the calendar without a coordinator chasing them.
A BD pipeline that isn't a spreadsheet
Stale conversations surface themselves. Next steps that went missing get flagged. The weekly digest writes itself.
Reputation and referral signal
For services businesses in the sector — CROs, CDMOs, consultancies — the request fires on delivery, not on a reminder someone set.
What this is not.
Not a GxP or validated systems project.
We work on the commercial and operational side: BD, marketing, finance ops, vendor and application management. We do not touch validated lab or quality systems, and we will tell you plainly when something is out of scope.
Not a rip-and-replace.
We start by mapping what you have. Most of the value in the first ninety days comes from retiring duplicates and connecting what you already own.
Your data and your subscriptions stay yours.
We administer on your behalf. If you leave, we hand over cleanly.
Your landlord understands your P&L.
Optivant OS was created by a COO of a 150,000+ square feet of life sciences infrastructure with more than 50 tenant companies. He is also volunteer President of BioStrategy Partners. Before all of that: twenty years in commercial banking, including dedicated life sciences coverage.
Which means the conversation starts further along. You do not have to explain what a Series A looks like, why the burn schedule matters, or why the CDMO relationship is the one that can't slip.
The full background